SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-150484
Filing Date
2023-05-22
Accepted
2023-05-22 16:15:56
Documents
14
Period of Report
2023-05-09
Items
Item 1.03: Bankruptcy or Receivership
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d470846d8k.htm   iXBRL 8-K 37790
2 EX-99.1 d470846dex991.htm EX-99.1 10478
6 GRAPHIC g470846g0522233428399.jpg GRAPHIC 3175
  Complete submission text file 0001193125-23-150484.txt   187318

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atnx-20230509.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atnx-20230509_lab.xml EX-101.LAB 18706
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atnx-20230509_pre.xml EX-101.PRE 11696
8 EXTRACTED XBRL INSTANCE DOCUMENT d470846d8k_htm.xml XML 3528
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Filer) CIK: 0001300699 (see all company filings)

IRS No.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38112 | Film No.: 23944626
SIC: 2834 Pharmaceutical Preparations